Kevin Kunzmann
MD Magazine
Cranbury Township, NJ, United States
Contact Kevin
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Kevin:
This Year in Medicine 2022: The Top HCPLive Stories of the Year
As we begin our annual health care recap series this month, let's take a look back at the stories our readers liked most. → Read More
GSK to Submit Older Adult RSV Vaccine Candidate to FDA in 2022
The decision comes after the company announced positive phase 3 data for the combination vaccine candidate in adults aged 60 years and older. → Read More
Gina Poe, PhD: How Psychiatric Diseases Impact Sleep Health
The UCLA-based investigator discusses the unique impact of PTSD on patients' sleep stages, and how they can limit their insomnia. → Read More
The Ketamine & Esketamine Care Teams, and Necessary Monitoring
With administration strategies for the psychiatric anesthetic drug well established, clinicians have interest in accumulating long-term data and other potential indications. → Read More
Blood Biomarkers, Aducanumab and Setting Precedent for Dementia Care Advances
Brent Forester, MD, MSc, discusses the confluence of biomarker and disease-targeting therapy in Alzheimer's, and the need to appropriately introduce these tools. → Read More
Melatonin Use for Sleep Is Climbing Among US Adults
New data show use exceeding the recommended daily dose for sleep aid has increased nearly 4-fold in the last 15 years. → Read More
Merck Receives FDA Complete Response Letter for Chronic Cough Drug Candidate Gefapixant
The selective inhibitor therapy is being investigated for the treatment of 2 forms of chronic cough—an indication that's been unmet in 60 years. → Read More
ACP Publishes New Guidelines for Diverticulitis Screening, Management, Treatment
The 6 recommendations across 2 expert-led guidelines address the role of colonoscopy, CT scans and elective surgery, among other subjects of care. → Read More
7 FDA Drug Decisions To Watch Through July 2022
From a new heart failure indication to a first-of-its-kind rare disease treatment, here's the most interesting PDUFA dates for the first half of the year. → Read More
Key Differences, Similarities Between COVID-19 and the Flu
Amid rising cases of both respiratory viruses, here is a guide for symptoms, complications, disease onset and illness duration. → Read More
Andrew Moran, MD, MPH: The Value of Earlier Lipid Intervention
Adults 40 years and younger generally aren't tested for lipid level risk—a byproduct of national guidance and clinical trial needs. → Read More
New Model Could Predict Cost of PDR Prevention with Aflibercept
A cost-based assessment of Protocol W and PANORAMA clinical data suggests diabetic retinopathy may be less costly to prevent than macular edema. → Read More
Bevacizumab Formulation Significantly Improves wAMD Vision Versus Ranibizumab in NORSE 2
Bevacizumab-vikg was associated with statistically significant improvements in patient BCVA scores over a period of 12 months, according to phase 3 findings. → Read More
Treat-and-Extend for Anti-VEGF May Provide More Optimal Dosing and Fewer Clinic Visits
A meta-analysis comparison of dosing regimens for patients with nAMD show little difference in efficacy, but differences in patient involvement in care. → Read More
Vorolanib via Durasert Provides Safe Treatment of Wet AMD Through 12 Months
A phase 1 trial of the investigative drug suggests its promise in a novel strategy of managing patients with retinal fluid. → Read More
Gene Therapy ADVM-022 Provides Mixed Efficacy, Safety in Treating DME
Findings from the phase 2 INFINITY suggest a more dose-dependent influence on safety outcomes in patients receiving sustained benefit for diabetic macular edema. → Read More
Reduced Retinal Fluid Linked to Better nAMD Visual Improvements
New HAWK and HARRIER findings show patients with fluid-free visits reported greater benefit in BVCA while receiving anti-VEGF. → Read More
Inflammatory Rheumatic Disease Linked to Reduced mRNA COVID-19 Vaccine Response
An assessment of a rheumatic disease cohort shows Spike protein antibody response is significantly decreased in vaccinated patients, and may vary by treatment. → Read More
Women, Alcohol Drinkers Are at Greater Risk of Methotrexate Side Effects
Alopecia and nausea risk may be more easily identified in patients initiating methotrexate for rheumatoid arthritis. → Read More
Pediatric Arthritis Linked to Households with Lower Income, Education
A cross-sectional analysis suggests patients with worse social risk scores are significantly more likely to be impacted by juvenile idiopathic arthritis. → Read More